ConductScience.org, home

Paper128144

Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.

Burdick JF and 2 others. Surg Gynecol Obstet, 1975. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. Papers, record 128144. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/128144

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
PubMed
Journal
Surg Gynecol Obstet
PubMed
Year
1975
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.57
iCite
Revised in PubMed
2020-12-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burdick JFJ F
2Wells SA JrS A
3Herberman RBR B

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypersensitivity, DelayedMajor topic
Intradermal TestsMajor topic
NeoplasmsMajor topic
Skin TestsMajor topic
Antigens
Antigens, Neoplasm
Arthus Reaction
Breast Neoplasms
Burkitt Lymphoma
Carcinoma
Colonic Neoplasms
Dinitrochlorobenzene
Female
Hodgkin Disease
Humans
Immunity
Leukemia
Leukocytes
Melanoma
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
7380461Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.Immunology1980https://conductscience.org/library/papers/7380461PubMed
2289200Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2289200PubMed
776107Critical analysis of treatment of stage II and stage III melanoma patients with immunotherapy.Ann Surg1976https://conductscience.org/library/papers/776107PubMed
627408Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.Immunology1978https://conductscience.org/library/papers/627408PubMed
497111Bovine ocular squamous-cell carcinoma: lymphocyte response to phytohaemagglutinin and tumour antigen.Br J Cancer1979https://conductscience.org/library/papers/497111PubMed
318786Cell-mediated immunity and its role in resistance to infection.West J Med1977https://conductscience.org/library/papers/318786PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/128144

GET https://conductscience.org/api/papers/v1/128144/authors